Biologic Breakthroughs for Severe Asthma with Dr. Mario Castro

Dr. Castro and Dr. Rizzo discuss the evolving world of monoclonal antibodies for the treatment of severe asthma. Plus, the ALA team discusses September's annual Asthma Peak Week, and what it means for reopening schools.See and read more Lungcast recaps and additional interviews at HCPLive.com/sap-partner/american-lung-association.Listen to Dr. Rizzo's interview with Dr. Anne Dixon on the 2020 asthma management guidelines here.Visit Lung.org for more resources and expert insights into respiratory disease management.Episode highlights 0:15 Back to school with Asthma Peak Week 9:48 Biologics: the emerging severe asthma treatment field 11:34 Defining type 2 inflammation and severe asthma 15:47 Severe asthma biomarkers 21:23 IL-4, IL-13, TSLP: Promising pathways 25:49 Severe asthma diagnostic clues 28:34 Asthma biologic decision-making 35:31 How long-term is a biologic therapy? 37:44 The future of asthma-modifying therapy 41:09 Understanding asthmatic COVID-19 risk 44:57 Outro